{"transactions":[{"id":950533,"issuer":{"id":7588,"kind":"organization","name":"Jasper Therapeutics, Inc."},"owners":[{"id":70274,"kind":"person","name":"CROSS HERB","position":1,"cik":"0001230721","reported_name":"CROSS HERB","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-01-05T19:30:17.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the shares subject to the option shall vest on January 2, 2027, and 1/48th of the original number of shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive."}],"balance_after":90000,"derivative":{"exercise_price":1.84,"expiration_date":"2036-01-02","underlying":"Voting Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001213900-26-001382","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1230721/000121390026001382/ownership.xml","form_type":"4"}},{"id":1119350,"issuer":{"id":7588,"kind":"organization","name":"Jasper Therapeutics, Inc."},"owners":[{"id":70274,"kind":"person","name":"CROSS HERB","position":1,"cik":"0001230721","reported_name":"CROSS HERB","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-06-06T06:25:18.000Z","date":"2025-06-04","kind":"grant","planned":false,"acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the shares subject to the retention option shall vest on June 4, 2026 and 1/48th of the shares subject to the retention option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive."}],"balance_after":90000,"derivative":{"exercise_price":6,"expiration_date":"2035-06-04","underlying":"Voting Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001213900-25-051724","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1230721/000121390025051724/ownership.xml","form_type":"4"}},{"id":1263449,"issuer":{"id":7588,"kind":"organization","name":"Jasper Therapeutics, Inc."},"owners":[{"id":70274,"kind":"person","name":"CROSS HERB","position":1,"cik":"0001230721","reported_name":"CROSS HERB","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-02-18T17:30:21.000Z","date":"2025-02-13","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the shares subject to the option shall vest on February 13, 2026, and 1/48th of the original number of shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive."}],"balance_after":50000,"derivative":{"exercise_price":6.2,"expiration_date":"2035-02-13","underlying":"Voting Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001213900-25-014949","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1230721/000121390025014949/ownership.xml","form_type":"4"}},{"id":1633066,"issuer":{"id":7588,"kind":"organization","name":"Jasper Therapeutics, Inc."},"owners":[{"id":70274,"kind":"person","name":"CROSS HERB","position":1,"cik":"0001230721","reported_name":"CROSS HERB","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-02-20T19:27:04.000Z","date":"2024-02-15","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the shares subject to the option shall vest on February 15, 2025, and 1/48th of the shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive."}],"balance_after":40000,"derivative":{"exercise_price":17.95,"expiration_date":"2034-02-15","underlying":"Voting Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001213900-24-015459","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1230721/000121390024015459/ownership.xml","form_type":"4"}},{"id":1773169,"issuer":{"id":7588,"kind":"organization","name":"Jasper Therapeutics, Inc."},"owners":[{"id":70274,"kind":"person","name":"CROSS HERB","position":1,"cik":"0001230721","reported_name":"CROSS HERB","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-09-26T16:16:09.000Z","date":"2023-09-22","kind":"grant","planned":false,"acquired":true,"shares":550000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the shares subject to the option shall vest on September 22, 2024, and 1/48th of the shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive."}],"balance_after":550000,"derivative":{"exercise_price":0.78,"expiration_date":"2033-09-22","underlying":"Voting Common Stock","underlying_shares":550000},"source":{"system":"sec-edgar","filing":"0001213900-23-079569","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1230721/000121390023079569/ownership.xml","form_type":"4"}},{"id":1796471,"issuer":{"id":110214,"kind":"organization","name":"Apexigen, Inc.","symbol":"APGN"},"owners":[{"id":70274,"kind":"person","name":"CROSS HERB","position":1,"cik":"0001230721","reported_name":"CROSS HERB","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-08-25T19:24:18.000Z","date":"2023-08-23","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares subject to the option vest in three equal annual installments beginning on July 29, 2023.  Pursuant to the Merger Agreement, at the Effective Time, the option was assumed by Pyxis and converted into an option to purchase 17,250 shares of Pyxis common stock at an exercise price of $15.37 per share. In accordance with the reporting person's equity award agreement, vesting of the unvested shares underlying the option accelerated in full at the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option vest in three equal annual installments beginning on July 29, 2023.  Pursuant to the Merger Agreement, at the Effective Time, the option was assumed by Pyxis and converted into an option to purchase 17,250 shares of Pyxis common stock at an exercise price of $15.37 per share. In accordance with the reporting person's equity award agreement, vesting of the unvested shares underlying the option accelerated in full at the Effective Time."}],"balance_after":0,"derivative":{"exercise_price":2.65,"expiration_date":"2032-09-29","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-23-047444","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1814140/000120919123047444/doc4.xml","form_type":"4"}},{"id":1796470,"issuer":{"id":110214,"kind":"organization","name":"Apexigen, Inc.","symbol":"APGN"},"owners":[{"id":70274,"kind":"person","name":"CROSS HERB","position":1,"cik":"0001230721","reported_name":"CROSS HERB","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-08-25T19:24:18.000Z","date":"2023-08-23","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":34084,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares subject to the option vest in 48 equal monthly installments beginning on November 3, 2019. Pursuant to an Agreement and Plan of Merger, dated as of May 23, 2023 (the \"Merger Agreement\"), by and among the Issuer, Pyxis Oncology, Inc. (\"Pyxis\"), and Ascent Merger Sub Corp., at the effective time of the merger (the \"Effective Time\"), the option was assumed by Pyxis and converted into an option to purchase 5,879 shares of Pyxis common stock at an exercise price of $40.24 per share. In accordance with the reporting person's equity award agreement, vesting of the unvested shares underlying the option accelerated in full at the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in 48 equal monthly installments beginning on November 3, 2019. Pursuant to an Agreement and Plan of Merger, dated as of May 23, 2023 (the \"Merger Agreement\"), by and among the Issuer, Pyxis Oncology, Inc. (\"Pyxis\"), and Ascent Merger Sub Corp., at the effective time of the merger (the \"Effective Time\"), the option was assumed by Pyxis and converted into an option to purchase 5,879 shares of Pyxis common stock at an exercise price of $40.24 per share. In accordance with the reporting person's equity award agreement, vesting of the unvested shares underlying the option accelerated in full at the Effective Time."}],"balance_after":0,"derivative":{"exercise_price":6.94,"expiration_date":"2029-11-08","underlying":"Common Stock","underlying_shares":34084},"source":{"system":"sec-edgar","filing":"0001209191-23-047444","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814140/000120919123047444/doc4.xml","form_type":"4"}},{"id":1814772,"issuer":{"id":91940,"kind":"organization","name":"Atreca, Inc.","symbol":"BCEL"},"owners":[{"id":70274,"kind":"person","name":"CROSS HERB","position":1,"cik":"0001230721","reported_name":"CROSS HERB","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2023-08-04T18:55:12.000Z","date":"2023-08-02","kind":"sale","planned":false,"acquired":false,"shares":5487,"price":0.9522,"value":5224.7214,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a \"sell to cover\" and does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.92 to\n$0.97 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the\nSecurities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the\nrange set forth in this footnote."}],"balance_after":72817,"source":{"system":"sec-edgar","filing":"0001209191-23-044684","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1230721/000120919123044684/doc4.xml","form_type":"4"}},{"id":2019569,"issuer":{"id":91940,"kind":"organization","name":"Atreca, Inc.","symbol":"BCEL"},"owners":[{"id":70274,"kind":"person","name":"CROSS HERB","position":1,"cik":"0001230721","reported_name":"CROSS HERB","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee stock option (right to buy)","published_at":"2023-02-13T20:58:32.000Z","date":"2023-02-09","kind":"grant","acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/48 of the Option vests in equal monthly installments as measured from January 1, 2023. If applicable, vesting accelerates as provided in, and subject to the terms and conditions of, that certain Executive Employment Agreement between the Issuer and the Reporting Person, as may be amended from time to time."}],"balance_after":175000,"derivative":{"exercise_price":1.49,"expiration_date":"2033-02-08","underlying":"Class A Common Stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0001209191-23-008957","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1230721/000120919123008957/doc4.xml","form_type":"4"}},{"id":2019568,"issuer":{"id":91940,"kind":"organization","name":"Atreca, Inc.","symbol":"BCEL"},"owners":[{"id":70274,"kind":"person","name":"CROSS HERB","position":1,"cik":"0001230721","reported_name":"CROSS HERB","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2023-02-13T20:58:32.000Z","date":"2023-02-09","kind":"grant","acquired":true,"shares":43750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person received an award of 43,750 restricted stock units on February 9, 2023, vesting in three equal annual installments beginning on August 1, 2023.  Each restricted stock unit represents a right to receive one share of Atreca Class A Common Stock upon vesting."}],"balance_after":78304,"source":{"system":"sec-edgar","filing":"0001209191-23-008957","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1230721/000120919123008957/doc4.xml","form_type":"4"}},{"id":2147544,"issuer":{"id":110214,"kind":"organization","name":"Apexigen, Inc.","symbol":"APGN"},"owners":[{"id":70274,"kind":"person","name":"CROSS HERB","position":1,"cik":"0001230721","reported_name":"CROSS HERB","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-10-03T17:57:36.000Z","date":"2022-09-29","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in three equal annual installments beginning on July 29, 2023."}],"balance_after":100000,"derivative":{"exercise_price":2.65,"expiration_date":"2032-09-29","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-22-051929","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814140/000120919122051929/doc4.xml","form_type":"4"}},{"id":2153942,"issuer":{"id":91940,"kind":"organization","name":"Atreca, Inc.","symbol":"BCEL"},"owners":[{"id":70274,"kind":"person","name":"CROSS HERB","position":1,"cik":"0001230721","reported_name":"CROSS HERB","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2022-09-20T18:11:46.000Z","date":"2022-09-02","kind":"sale","acquired":false,"shares":7646,"price":1.7752,"value":13573.1792,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a \"sell to cover\" and does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $1.74 to $1.83 per share, inclusive.  The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":34554,"source":{"system":"sec-edgar","filing":"0001209191-22-050777","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1230721/000120919122050777/doc4.xml","form_type":"4"}},{"id":2231232,"issuer":{"id":91940,"kind":"organization","name":"Atreca, Inc.","symbol":"BCEL"},"owners":[{"id":70274,"kind":"person","name":"CROSS HERB","position":1,"cik":"0001230721","reported_name":"CROSS HERB","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee stock option (right to buy)","published_at":"2022-06-15T19:14:45.000Z","date":"2022-06-13","kind":"disposition_to_issuer","acquired":false,"shares":97000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"2/48 of the Option vests on 3/1/2020 and 1/48 of the Option vests in equal monthly installments as measured from 3/1/2020. If applicable, vesting accelerates as provided in, and subject to the terms and conditions of, that certain Executive Employment Agreement between the Issuer and the Reporting Person, as may be amended from time to time."}],"balance_after":0,"derivative":{"exercise_price":22.07,"expiration_date":"2030-02-25","underlying":"Class A Common Stock","underlying_shares":97000},"source":{"system":"sec-edgar","filing":"0001209191-22-037111","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1230721/000120919122037111/doc4.xml","form_type":"4"}},{"id":2231231,"issuer":{"id":91940,"kind":"organization","name":"Atreca, Inc.","symbol":"BCEL"},"owners":[{"id":70274,"kind":"person","name":"CROSS HERB","position":1,"cik":"0001230721","reported_name":"CROSS HERB","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee stock option (right to buy)","published_at":"2022-06-15T19:14:45.000Z","date":"2022-06-13","kind":"grant","acquired":true,"shares":97000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a one-time stock option repricing effective on June 13, 2022 (the \"Option Repricing\"). The Option Repricing applies to options with exercise prices greater than or equal to $9.00 per share held by all employees of the Issuer as of June 13, 2022.  Pursuant to the Option Repricing, the exercise price of the repriced options, including the Option, has been amended to reduce the exercise price to $1.845 per share, the closing price of the Issuer's Class A common stock on the Nasdaq Global Select Market as of the date of the Option Repricing. There have been no other changes to the terms of the repriced options, including the Option.  The Option Repricing does not apply to options held by non-employee directors of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"2/48 of the Option vests on 3/1/2020 and 1/48 of the Option vests in equal monthly installments as measured from 3/1/2020. If applicable, vesting accelerates as provided in, and subject to the terms and conditions of, that certain Executive Employment Agreement between the Issuer and the Reporting Person, as may be amended from time to time."}],"balance_after":97000,"derivative":{"exercise_price":1.845,"expiration_date":"2030-02-25","underlying":"Class A Common Stock","underlying_shares":97000},"source":{"system":"sec-edgar","filing":"0001209191-22-037111","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1230721/000120919122037111/doc4.xml","form_type":"4"}},{"id":2231230,"issuer":{"id":91940,"kind":"organization","name":"Atreca, Inc.","symbol":"BCEL"},"owners":[{"id":70274,"kind":"person","name":"CROSS HERB","position":1,"cik":"0001230721","reported_name":"CROSS HERB","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee stock o16.74ption (right to buy)","published_at":"2022-06-15T19:14:45.000Z","date":"2022-06-13","kind":"disposition_to_issuer","acquired":false,"shares":224999,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/4 of the Option vests on 2/25/2020 and 1/48 of the Option vests in equal monthly installments as measured from 2/25/2020. If applicable, vesting accelerates as provided in, and subject to the terms and conditions of, that certain Executive Employment Agreement between the Issuer and the Reporting Person, as may be amended from time to time."}],"balance_after":0,"derivative":{"exercise_price":12.06,"expiration_date":"2029-04-04","underlying":"Class A Common Stock","underlying_shares":224999},"source":{"system":"sec-edgar","filing":"0001209191-22-037111","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1230721/000120919122037111/doc4.xml","form_type":"4"}},{"id":2231229,"issuer":{"id":91940,"kind":"organization","name":"Atreca, Inc.","symbol":"BCEL"},"owners":[{"id":70274,"kind":"person","name":"CROSS HERB","position":1,"cik":"0001230721","reported_name":"CROSS HERB","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee stock option (right to buy)","published_at":"2022-06-15T19:14:45.000Z","date":"2022-06-13","kind":"grant","acquired":true,"shares":224999,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a one-time stock option repricing effective on June 13, 2022 (the \"Option Repricing\"). The Option Repricing applies to options with exercise prices greater than or equal to $9.00 per share held by all employees of the Issuer as of June 13, 2022.  Pursuant to the Option Repricing, the exercise price of the repriced options, including the Option, has been amended to reduce the exercise price to $1.845 per share, the closing price of the Issuer's Class A common stock on the Nasdaq Global Select Market as of the date of the Option Repricing. There have been no other changes to the terms of the repriced options, including the Option.  The Option Repricing does not apply to options held by non-employee directors of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/4 of the Option vests on 2/25/2020 and 1/48 of the Option vests in equal monthly installments as measured from 2/25/2020. If applicable, vesting accelerates as provided in, and subject to the terms and conditions of, that certain Executive Employment Agreement between the Issuer and the Reporting Person, as may be amended from time to time."}],"balance_after":224999,"derivative":{"exercise_price":1.845,"expiration_date":"2029-04-04","underlying":"Class A Common Stock","underlying_shares":224999},"source":{"system":"sec-edgar","filing":"0001209191-22-037111","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1230721/000120919122037111/doc4.xml","form_type":"4"}},{"id":2231228,"issuer":{"id":91940,"kind":"organization","name":"Atreca, Inc.","symbol":"BCEL"},"owners":[{"id":70274,"kind":"person","name":"CROSS HERB","position":1,"cik":"0001230721","reported_name":"CROSS HERB","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee stock option (right to buy)","published_at":"2022-06-15T19:14:45.000Z","date":"2022-06-13","kind":"disposition_to_issuer","acquired":false,"shares":95000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48 of the Option vests in equal monthly installments as measured from 1/1/2021. If applicable, vesting accelerates as provided in, and subject to the terms and conditions of, that certain Executive Employment Agreement between the Issuer and the Reporting Person, as may be amended from time to time."}],"balance_after":0,"derivative":{"exercise_price":13.97,"expiration_date":"2031-01-26","underlying":"Class A Common Stock","underlying_shares":95000},"source":{"system":"sec-edgar","filing":"0001209191-22-037111","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1230721/000120919122037111/doc4.xml","form_type":"4"}},{"id":2231227,"issuer":{"id":91940,"kind":"organization","name":"Atreca, Inc.","symbol":"BCEL"},"owners":[{"id":70274,"kind":"person","name":"CROSS HERB","position":1,"cik":"0001230721","reported_name":"CROSS HERB","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee stock option (right to buy)","published_at":"2022-06-15T19:14:45.000Z","date":"2022-06-13","kind":"grant","acquired":true,"shares":95000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transactions reported herein reflect a one-time stock option repricing effective on June 13, 2022 (the \"Option Repricing\"). The Option Repricing applies to options with exercise prices greater than or equal to $9.00 per share held by all employees of the Issuer as of June 13, 2022.  Pursuant to the Option Repricing, the exercise price of the repriced options, including the Option, has been amended to reduce the exercise price to $1.845 per share, the closing price of the Issuer's Class A common stock on the Nasdaq Global Select Market as of the date of the Option Repricing. There have been no other changes to the terms of the repriced options, including the Option.  The Option Repricing does not apply to options held by non-employee directors of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48 of the Option vests in equal monthly installments as measured from 1/1/2021. If applicable, vesting accelerates as provided in, and subject to the terms and conditions of, that certain Executive Employment Agreement between the Issuer and the Reporting Person, as may be amended from time to time."}],"balance_after":95000,"derivative":{"exercise_price":1.845,"expiration_date":"2031-01-26","underlying":"Class A Common Stock","underlying_shares":95000},"source":{"system":"sec-edgar","filing":"0001209191-22-037111","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1230721/000120919122037111/doc4.xml","form_type":"4"}},{"id":2457784,"issuer":{"id":91940,"kind":"organization","name":"Atreca, Inc.","symbol":"BCEL"},"owners":[{"id":70274,"kind":"person","name":"CROSS HERB","position":1,"cik":"0001230721","reported_name":"CROSS HERB","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee stock option (right to buy)","published_at":"2021-12-28T18:51:35.000Z","date":"2021-12-23","kind":"grant","acquired":true,"shares":95000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48 of the Option vests in equal monthly installments as measured from 12/1/2021. If applicable, vesting accelerates as provided in, and subject to the terms and conditions of, that certain Executive Employment Agreement between the Issuer and the Reporting Person, as may be amended from time to time. Early Exercise is not permitted."}],"balance_after":95000,"derivative":{"exercise_price":3.18,"expiration_date":"2031-12-22","underlying":"Class A Common Stock","underlying_shares":95000},"source":{"system":"sec-edgar","filing":"0001209191-21-071426","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1230721/000120919121071426/doc4.xml","form_type":"4"}},{"id":2571846,"issuer":{"id":91940,"kind":"organization","name":"Atreca, Inc.","symbol":"BCEL"},"owners":[{"id":70274,"kind":"person","name":"CROSS HERB","position":1,"cik":"0001230721","reported_name":"CROSS HERB","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-09-13T21:45:13.000Z","date":"2021-09-09","kind":"grant","acquired":true,"shares":42200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares of common stock are to be acquired upon the vesting of a restricted stock unit award granted to the Reporting Person. The restricted stock unit award shall vest as follows: vest over two years (vesting commencement date = September 1, 2021), with a one-year cliff as follows: on the first anniversary of the vesting commencement date, 50% of the restricted stock unit award shall vest, and on the second anniversary of the vesting commencement date, 50% of the restricted stock unit award shall vest. In total, 100% of the restricted stock unit award shall be vested on the second anniversary of the vesting commencement date."}],"balance_after":42200,"source":{"system":"sec-edgar","filing":"0001209191-21-055808","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1230721/000120919121055808/doc4.xml","form_type":"4"}},{"id":2890062,"issuer":{"id":91940,"kind":"organization","name":"Atreca, Inc.","symbol":"BCEL"},"owners":[{"id":70274,"kind":"person","name":"CROSS HERB","position":1,"cik":"0001230721","reported_name":"CROSS HERB","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee stock option (right to buy)","published_at":"2021-01-29T20:26:35.000Z","date":"2021-01-27","kind":"grant","acquired":true,"shares":95000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48 of the Option vests in equal monthly installments as measured from 1/1/2021. If applicable, vesting accelerates as provided in, and subject to the terms and conditions of, that certain Executive Employment Agreement between the Issuer and the Reporting Person, as may be amended from time to time."}],"balance_after":95000,"derivative":{"exercise_price":13.97,"expiration_date":"2031-01-26","underlying":"Class A Common Stock","underlying_shares":95000},"source":{"system":"sec-edgar","filing":"0001209191-21-006336","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1230721/000120919121006336/doc4.xml","form_type":"4"}},{"id":3240901,"issuer":{"id":91940,"kind":"organization","name":"Atreca, Inc.","symbol":"BCEL"},"owners":[{"id":70274,"kind":"person","name":"CROSS HERB","position":1,"cik":"0001230721","reported_name":"CROSS HERB","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee stock opiton (right to buy)","published_at":"2020-02-28T17:29:27.000Z","date":"2020-02-26","kind":"grant","acquired":true,"shares":97000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"2/48 of the Option vests on 3/1/2020 and 1/48 of the Option vests in equal monthly installments as measured from 3/1/2020.  If applicable, vesting accelerates as provided in, and subject to the terms and conditions of, that certain Executive Employment Agreement between the Issuer and the Reporting Person, as may be amended from time to time."}],"balance_after":97000,"derivative":{"exercise_price":22.07,"expiration_date":"2030-02-25","underlying":"Class A Common Stock","underlying_shares":97000},"source":{"system":"sec-edgar","filing":"0001209191-20-014069","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1230721/000120919120014069/doc4.xml","form_type":"4"}},{"id":3885168,"issuer":{"id":12201,"kind":"organization","name":"ARMO BioSciences, Inc.","symbol":"ARMO"},"owners":[{"id":70274,"kind":"person","name":"CROSS HERB","position":1,"cik":"0001230721","reported_name":"CROSS HERB","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-06-22T17:13:26.000Z","date":"2018-06-22","kind":"disposition_to_issuer","acquired":false,"shares":240658,"price":43.0302,"value":10355561.8716,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated May 9, 2018, by and among the Issuer, Eli Lilly and Company (\"Parent\") and Bluegill Acquisition Corporation (\"Merger Sub\"), a wholly-owned subsidiary of Parent, Merger Sub made a cash tender offer (the \"Offer\") to purchase each outstanding share of the Issuer's common stock for $50.00 per share (the \"Offer Price\"), net to the seller in cash, without interest and less any applicable tax withholding. These shares were tendered into the Offer and, after the expiration of the Offer at one minute after 11:59 pm Eastern Time on June 21, 2018, Merger Sub accepted all of the tendered shares and the holder was entitled to receive the Offer Price per share."},{"field":"shares","element":"transactionShares","label":"F2","text":"Pursuant to the Merger Agreement, each outstanding option to purchase shares of the Issuer's common stock, whether or not exercisable or vested, was cancelled and the holder thereof became entitled to receive an amount in cash determined by multiplying (A) the excess, if any, of $50.00 over the exercise price per share of the common stock underlying such stock option by (B) the number of shares of common stock subject to such stock option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option, which provided for vesting in forty-eight equal monthly installments following November 27, 2017, subject to a one-year cliff, was cancelled and the Reporting Person became entitled to receive an amount in cash per the terms of the Merger Agreement, as described in footnote (2) above."}],"balance_after":0,"derivative":{"exercise_price":6.9698,"expiration_date":"2027-12-12","underlying":"Common Stock","underlying_shares":240658},"source":{"system":"sec-edgar","filing":"0000899243-18-017716","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1693664/000089924318017716/doc4.xml","form_type":"4"}}]}